Physician profile
Mark A Kosinski
NPI 1295770048
$2,101.59
in general payments reported to CMS, 2019-2025
10 companies · $206 in 2025
The $206 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2020: $15.44 · 2021: $1,420 · 2022: $42.73 · 2023: $290 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $496.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $496.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $1,280.00 | 2021 | |
| Abbott Laboratories | $514.58 | 2021-2025 | Esprit, Supera |
| Djo, LLC | $109.65 | 2023 | Cmf |
| Csl Behring | $74.76 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $40.00 | 2019 | |
| Nevro Corp. | $24.75 | 2022 | |
| Horizon Therapeutics Plc | $17.98 | 2022 | |
| Next Science LLC | $15.44 | 2020 | |
| Smith+Nephew, INC. | $12.72 | 2019 | |
| Kci USA, INC. | $11.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Kosinski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.